human therapy evaluation
Showing 1 - 25 of >10,000
Schizophrenia, Art Therapy, Social Support Trial in Ankara (Visual Arts Group Therapy Based On Watson's Human Care Model,
Completed
- Schizophrenia
- +2 more
- Vısual Arts Group Therapy Based On Watson's Human Care Model
- Ongoing treatment
-
Ankara, Çankaya, TurkeyGazi University
Jul 12, 2023
Human Immunodeficiency Virus, Treatment, Antiretroviral Therapy Trial in Seattle (TLC-ART)
Recruiting
- Human Immunodeficiency Virus
- +2 more
-
Seattle, WashingtonUW Positve Research, Harborview Medical Center
May 8, 2023
Oropharynx Cancer Trial in Miami (MRIdian Linac)
Not yet recruiting
- Oropharynx Cancer
- MRIdian Linac
-
Miami, FloridaThe University of Miami Sylvester Comprehensive Cancer Center
May 5, 2023
Pertussis/Whooping Cough Trial in Southampton (Bordetella pertussis B1917, Azithromycin Pill)
Recruiting
- Pertussis/Whooping Cough
- Bordetella pertussis B1917
- Azithromycin Pill
-
Southampton, Hampshire, United KingdomNIHR Clinical Research Facility
Apr 26, 2023
Periodontitis Trial in Beijing (Human Dental Fulp Stem Cells)
Not yet recruiting
- Periodontitis
- Human Dental Fulp Stem Cells
-
Beijing, Beijng, ChinaPeking University Third Hospital
Jun 20, 2023
Liver Cirrhosis Trial (Human albumin, Enoxaparin, Standard medical treatment)
Not yet recruiting
- Liver Cirrhosis
- Human albumin
- +2 more
- (no location specified)
Jun 6, 2023
Phelan-McDermid Syndrome, Growth Hormone Treatment Trial in Wuxi (recombinant human growth hormone, Saline)
Completed
- Phelan-McDermid Syndrome
- Growth Hormone Treatment
- recombinant human growth hormone
- Saline
-
Wuxi, Jiangsu, ChinaAffiliated Hospital of JiangNan University, Department of Pediat
Oct 7, 2022
ADHD - Combined Type Trial in Los Angeles (Flashed Light Therapy, Videoconference-delivered Cognitive Behavioral Therapy)
Recruiting
- ADHD - Combined Type
- Flashed Light Therapy
- Videoconference-delivered Cognitive Behavioral Therapy
-
Los Angeles, CaliforniaSemel Institute for Neuroscience and Human Behavior, University
Sep 6, 2023
Primary Hepatocellular Carcinoma, Portal Vein Thrombosis Trial (Recombinant human adenovirus type 5 + TACE)
Not yet recruiting
- Primary Hepatocellular Carcinoma
- Portal Vein Thrombosis
- Recombinant human adenovirus type 5 + TACE
- (no location specified)
May 14, 2023
ARDS, Human Trial (intravenous delivery of allogeneic bone marrow-derived MSCs)
Not yet recruiting
- ARDS, Human
- intravenous delivery of allogeneic bone marrow-derived MSCs
- (no location specified)
Aug 5, 2022
Neuronal Ceroid Lipofuscinosis Type 2 Trial in London (RGX-381)
Not yet recruiting
- Neuronal Ceroid Lipofuscinosis Type 2
- RGX-381
-
London, United KingdomGreater Ormond Street Hospital
Mar 17, 2023
Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Rochester (Durvalumab, Radiation Therapy)
Not yet recruiting
- Lung Non-Small Cell Carcinoma
- Stage III Lung Cancer AJCC v8
- Durvalumab
- Radiation Therapy
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
HIV Trial in Washington (Antiretroviral Therapy Interruption(ATI))
Enrolling by invitation
- HIV
- Antiretroviral Therapy Interruption(ATI)
-
Washington, District of Columbia
- +1 more
Sep 12, 2022
Post Traumatic Stress Disorder Trial in San Antonio (device, other, behavioral)
Recruiting
- Post Traumatic Stress Disorder
- Soterix 1x1 tDCS mini CT
- +2 more
-
San Antonio, TexasThe University of Texas Health Science Center at San Antonio
Jan 10, 2023
Chronic Ischemic Left Ventricular Dysfunction Trial (Human Embryonic Stem Cell-Derived Cardiomyocyte 50M cells, Human Embryonic
Recruiting
- Chronic Ischemic Left Ventricular Dysfunction
- Human Embryonic Stem Cell-Derived Cardiomyocyte 50M cells
- +2 more
-
Palo Alto, CaliforniaStanford Hospital and Clinics
Sep 15, 2022
Infertility, Female Trial in Changsha (human umbilical cord mesenchymal stem cell complex collagen, intrauterine injection)
Recruiting
- Infertility, Female
- human umbilical cord mesenchymal stem cell complex collagen
- intrauterine injection
-
Changsha, Hunan, ChinaXiangya Hospital Central South University
Aug 8, 2022
HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)
Recruiting
- HR+/HER2- Advanced Breast Cancer
- Targeted Therapy
- Everolimus
- +3 more
-
Beijing, Beijing, ChinaNational Cancer Center/National Clinical Research Center for Can
Aug 1, 2023
Colo-rectal Cancer Trial (biological, drug, procedure)
Not yet recruiting
- Colo-rectal Cancer
- Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine
- +8 more
- (no location specified)
Aug 28, 2023
Multiple Myeloma Trial in Shanghai, Wenzhou (Human BCMA Targeted T Cells Injection)
Recruiting
- Multiple Myeloma
- Human BCMA Targeted T Cells Injection
-
Shanghai, Shanghai, China
- +1 more
Dec 7, 2022
Gastrointestinal Microbiome, Exercise Trial in Fort Collins, New Brunswick (Azithromycin)
Not yet recruiting
- Gastrointestinal Microbiome
- Exercise
-
Fort Collins, Colorado
- +1 more
Jul 17, 2023
Necrotizing Fasciitis Trial in Augusta (Acellular Fish Skin Graft (AFS) and Negative Pressure Wound Therapy (NPWT), Acellular
Recruiting
- Necrotizing Fasciitis
- Acellular Fish Skin Graft (AFS) and Negative Pressure Wound Therapy (NPWT)
- Acellular Human Cadaver (AHC) and Negative Pressure Wound Therapy (NPWT)
-
Augusta, GeorgiaJoseph M. Still Research Foundation
Oct 2, 2023
Renal Anemia Trial in Hanzhou (Recombinant human erythropoietin injection, Human erythropoietin injection)
Recruiting
- Renal Anemia
- Recombinant human erythropoietin injection
- Human erythropoietin injection
-
Hanzhou, Zhejiang, ChinaThe First Affiliated Hospitial,College of Medicine,Zhejiang Univ
Nov 17, 2022
Recurrent Brain Tumor Trial in Houston (biological, other, radiation)
Active, not recruiting
- Recurrent Brain Neoplasm
- Bevacizumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 9, 2022
Lymphoma Trial in Seattle (biological, other, procedure)
Not yet recruiting
- Lymphoma
- Immune Globulin Infusion (Human), 10% Solution
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 21, 2023
B-cell Non-Hodgkin's Lymphoma Trial in Shanghai (Human CD19Targeted T Cells Injection)
Recruiting
- B-cell Non-Hodgkin's Lymphoma
- Human CD19Targeted T Cells Injection
-
Shanghai, Shanghai, ChinaZhongshan Hospital, Fudan University
Jun 29, 2022